LI

Healthcare · Pharmaceuticals

Lincoln Pharmaceuticals Ltd (LINCOLN)

₹511.90

Mkt cap
₹1,046 Cr
P/E ratio
10.80
P/B
1.26
Div yield
0.34%
ROE
12.00%
ROCE
16.00%
EPS (TTM)
₹47.40
Book value
₹405
52W range
440–770
Sector
Healthcare

Price history

Previous close

Incorporated in 1979, Lincoln Pharmaceuticals Ltd is in the business of manufacturing and trading of pharmaceutical products [1]

NSE LINCOLNBSE 531633
Health check
Mixed
ValuationCheap
ProfitabilityAverage
GrowthModerate
TechnicalsBearish
52-week range
−33.52% from high
₹512
₹440+16.34% from low₹770
Current
₹511.90
Prev close
₹512.05
Day
−0.03%
Price performance
1D
−0.21%
1W
−2.12%
1M
+0.03%
3M
−17.92%
6M
−30.21%
1Y
−2.80%
YTD
+2.97%

Financials

Revenue, profit & margin
P/E ratio
10.8×
LINCOLN is 68% below the sector median of 34.0×
LINCOLN10.8×
Sector median34.0×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales156146142147161147168154163166187177191
YoY Sales growth+11%+9%+27%+9%+3%+0%+18%+5%+1%+13%+11%+15%+17%
Expenses125117124125133123141130138143162150168
Operating Profit31301823282427242524252724
OPM %20%20%13%15%18%16%16%15%16%14%13%15%12%
Other Income911710109-715715-42410
Interest0000010000000
Depreciation3333333344444
Profit before tax37382229352916352935174829
Tax %25%26%16%20%24%28%29%22%31%18%30%24%30%
Net Profit28281924262112282029123620
EPS in Rs13.8014.009.2911.8213.1510.375.7813.829.9814.285.8118.0910.20
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −0.20% · closed higher next day 22 of last 43
 Q3FY24Q4FY24Q1FY25Q2FY25Q3FY25Q4FY25Q1FY26Q2FY26Q3FY26Q4FY26Q1FY27Q2FY27
Broadcast8 Feb '2416 May '24◦8 Aug '2414 Nov '2413 Feb '2522 May '25◦7 Aug '2513 Nov '25◦12 Feb '26◦28 May '26◦13 Aug '2629 Oct '26
Earnings day−2.10%+0.86%−1.94%−2.03%−3.51%+1.61%+13.17%+3.89%+6.25%−16.51%+4.50%−2.08%
+1 day−1.96%+0.59%−0.31%−2.44%−15.45%+1.81%+5.87%+5.31%+1.26%−20.04%+3.47%+0.45%
+5 days−5.19%−0.94%−1.15%−2.22%−15.08%−1.41%+2.17%+4.57%+1.10%−17.49%+5.02%−0.46%
+15 days+1.93%+5.11%+6.67%+51.48%−14.84%+6.58%+2.30%−2.54%+0.13%−18.93%+5.03%—
+30 days−10.50%+12.63%+9.82%+25.13%−16.92%+2.24%+3.63%−6.59%−3.40%−19.48%−0.31%—
FilingXBRLXBRLXBRLXBRLXBRLXBRLXBRLXBRLXBRLXBRLXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
49.78%Promoter
Promoters49.78%
FIIs4.55%0.05
DIIs0.02%0.25
Public45.65%0.29
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,880.0036.664,51,0750.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,442.0088.893,03,7490.26%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,670.0081.821,77,6320.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,424.0097.751,30,9720.08%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,189.9026.201,18,6930.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,380.0041.171,15,2670.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,391.8036.211,12,4420.93%852−35.05%7,404−2.44%15.49%
Lincoln Pharma.₹522.0510.791,0460.34%20+2.25%191+17.13%16.02%
Median: 160 Co.₹465.8333.992,0120.08%13+33.53%179+20.92%14.94%

Filings